Negative regulation of long-term synaptic potentiation

pathway activity — cross-omics
GO:1900272Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of long-term synaptic potentiation pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are KRT8P25, SIGLEC10, and RNA5SP383, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of long-term synaptic potentiation activity versus KRT8P25 in GBM (Pearson r = -0.26).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMKRT8P25 →-0.020-0.225.004<.00133
BRCASIGLEC10 →+0.551+0.200.002.00333
LUADRNA5SP383 →+0.579+0.390.007.00533
LUADCOL23A1 →+0.283+0.345.006<.00133
PDACPRKG2 →-0.440-0.581.005.00732
PDACACTL10 →-0.147-0.627<.001.00232
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1900272 vs KRT8P25 — GBM

Per-sample scatter of Negative regulation of long-term synaptic potentiation activity vs KRT8P25 in GBM.

Explore this scatter interactively →

Exploration